Adoption footprint ArcheMedX Ready is already deployed across 90 countries with 250,000+ clinical professionals, appealing to global pharma sponsors, emerging biotechs, and CROs seeking scalable training and trial risk reduction.

Performance driven The platform focuses on improving team and clinician performance by early risk identification and tailored on-demand training, aligning with sponsors’ goals to accelerate trial timelines and site activation.

High renewal signal Customer metrics show a strong renewal and expansion rate once Ready is deployed, indicating satisfied users and potential for upsell into broader modules such as rater training, CRA training, and workforce development.

Integrated workflow Ready supports protocol and site feasibility, naïve site readiness, training, site initiation, and patient education readiness, presenting cross-sell opportunities across trial planning, execution, and patient engagement activities.

Emerging needs Upcoming features like patient education and broader workforce development capabilities position ArcheMedX to address evolving regulatory, operational, and training needs in clinical trials, enabling expansion into new use cases and larger customer logos.